Şunu aradınız:: modest lowering effects (İngilizce - Maltaca)

the blood pressure lowering effects of irbesartan and thiazide-type diuretics are additive.
l-effetti ta' irbesartan u dijuretiċi tat-tip thiazide li jniżżlu il-pressjoni huma addittivi.

the total and maximum-glucose-lowering effects of ryzodeg increase linearly with increasing doses.
effetti totali u massimi ta' ryzodeg li jbaxxi l-glukosju jiżdiedu b'mod lineari ma' żieda fid-dożi.

the modest lowering effects on bp were consistent over time and a similar number of subjects had systolic bp < 130 mmhg or diastolic bp < 80 mmhg at week 24 across the treatment groups.
l-effetti modesti li jbaxxu l-bp kienu konsistenti maż-żmien u numru simili ta' individwi kellhom bp sistolika < 130 mmhg jew bp dijastolika < 80 mmhg fil-Ġimgħa 24 matul il-gruppi ta' kura.

the blood pressure lowering effects of amlodipine adds to the blood pressure-lowering effects of other antihypertensive medicinal products.
l-effetti ta’ tbaxxija tal-pressjoni tad-demm li għandu amlodipine jiżdiedu mal-effetti tat- tbaxxija tal-pressjoni tad-demm li għandhom prodotti mediċinali oħrajn kontra l-pressjoni għolja.

alcohol may intensify and prolong the glucose lowering effect of insulin.
l- alko ol jista ’ jintensifika u jtawwal l- effetti ipogli emi i ta ’ l- insulina.

a more pronounced glucose-lowering effect was observed in obese patients.
effett ieħor aktar ċar ta’ nuqqas ta’ glukosju ġie osservat f’pazjenti ħoxnin ħafna.

metformin may exert its glucose-lowering effect via three mechanisms:
metformin jista’ jeżerċita l-effett tiegħu li jnaqqas il-glucose permezz ta’ tlett mekkaniżmi:

total glucose-lowering effect of tresiba increases linearly with increasing doses.
l-effett totali tat-tnaqqis tal-livell tal-glukosju ta' tresiba jiżdied b'mod lineari ma' żieda fid-dożi.

the blood glucose-lowering effect of oral hypoglycaemic agents decreases in many patients over time.
12 l- effett ta 'sustanzi ipogliċemiċi, orali, li jbaxxu l- glucose fid- demm maż- żmien jonqos f' ħafna pazjenti.

the maximal blood pressure lowering effect should be reached 4-6 weeks after beginning treatment.
l-effett massimu biex tinżel il-pressjoni tad-demm għandu jintlaħaq 4-6 ġimgħat wara li tinbeda l- kura.

there is a potential for the iop-lowering effect of prostaglandin analogues (e.g.
hemm il-potenzjal li l-effett ta’ analogi ta’ prostaglandin li jbaxxu iop (eż.

riociguat: preclinical studies showed additive systemic blood pressure lowering effect when pde5 inhibitors were combined with riociguat.
riociguat:studji prekliniċi wrew żieda fl-effett li titbaxxa l-pressjoni sistemika tad-demm meta inibituri ta’ pde5 intużaw flimkien ma’ riociguat.

85 to 90% of the maximal blood- pressure-lowering effect was observed after 2 weeks.
85 sa 90% ta’ l-effett massimu li jbaxxi l-pressjoni deher wara ġimgħatejn.

day-to-day variability in glucose-lowering effect during one dosing interval (aucgir,τ,ss)
varjabilità minn jum għal jum fl-effett li jbaxxi l-glukosju waqt intervall ta' dożaġġ

day-to-day variability in glucose-lowering effect from 2- 24 hours (aucgir2-24h,ss)
varjabilità minn jum għal jum fl-effett li jbaxxi l-glukosju minn 2-24 siegħa (aucgir2-24h,ss)